Table 3.
Multivariate and univariate Cox regression analysis on mortality at 30-day models
| Univariate analysis hazard ratio (95% CI) | p value | Multivariate analysis hazard ratio (95% CI) | p value | |
|---|---|---|---|---|
| Age, y | 1.06 (1.02–1.07) | < 0.001 | 1.05 (1.02–1.08) | < 0.001 |
| Cancer | 3.13 (1.75–5.63) | < 0.001 | 1.88 (0.96–3.70) | 0.067 |
| Respiratory rate | 1.06 (1.03–1.10) | 0.001 | 1.06 (1.01–1.11) | 0.020 |
| Oxygen saturation | 0.96 (0.94–0.97) | < 0.001 | 0.98 (0.96–1.01) | 0.280 |
| Creatinine | 1.00 (1.00–1.01) | 0.007 | 1.00 (1.00—1.01) | 0.226 |
| C-reactive protein | 1.00 (1.00–1.01) | 0.007 | 1.00 (1.00–1.01) | 0.696 |
| Brain natriuretic peptide | 1.00(1.00–1.00) | < 0.001 | 1.00 (1.00–1.00) | 0.049 |
| Hemoglobin | 0.74 (0.65–0.84) | < 0.001 | 0.80 (0.69–0.93) | 0.004 |
| CT severity score < 7/≥ 7 adding GGO and consolidation | 4.33 (2.25–8.32) | < 0.001 | 3.16 (1.50–6.43) | 0.001 |
| COPD | 2.41 (1.08–5.36) | 0.032 | ||
| DBP | 0.98 (0.96–1.00) | 0.015 | ||
| High-sensitivity Troponin I | 1.00 (1.00–1.00) | 0.034 | ||
| Lymphocytes | 1.03 (1.01–1.04) | 0.008 | ||
| Heart rate, bpm | 0.98 (0.97–1.00) | 0.039 | ||
| Oral anticoagulant | 2.34 (1.17–4.70) | 0.017 | ||
| Coronary artery disease | 1.92 (0.86–4.29) | 0.110 | ||
| History of heart failure | 1.64 (0.40–6.78) | 0.492 | ||
| Hypercholesterolemia | 0.93 (0.49–1.75) | 0.811 | ||
| History of smoking | 0.77 (0.39–1.50) | 0.437 | ||
| Days from illness onset to CT | 0.99 (0.89–1.05) | 0.891 | ||
| D-dimer, μg/mL | 1.00 (1.00–1.00) | 0.299 | ||
| Male | 0.84 (0.46–1.53) | 0.570 | ||
| BMI | 1.00 (0.94–1.07) | 0.953 | ||
| Statins | 0.70 (0.327–1.494) | 0.356 | ||
| Aspirin | 0.97 (0.45–2.06) | 0.926 | ||
| Diabetes mellitus | 0.85 (0.42–1.71) | 0.652 | ||
| Hypertension | 1.49 (0.85–2.63) | 0.167 |
Footnotes: Hazard ratio (HR) is calculated with each per unit-increase. Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; BMI, body mass index in kg/m2; DBP, diastolic blood pressure